Symposium - Mumbai, India
The NCE Research Division of Piramal Life Sciences (a vertical of Piramal Enterprises Limited) is organizing a 2- day international symposium on "MIF in Health and Disease". This symposium will be held on November 1-2, 2012 in Mumbai (India).
Macrophage migration inhibitory factor (MIF), one of the first soluble immunomodulator discovered, is a pleiotropic cytokine with wide-ranging cellular and biological activities. A growing body of evidence from in vitro, in vivo and most importantly, clinically-relevant studies implicates MIF: in the pathogenesis of oncologic disorders, diabetes/metabolic syndrome, a variety of inflammatory and auto-immune diseases, and also an array of infectious diseases. Given this, MIF is an active area of academic and more importantly, industrial research. Several investigators have adopted a synergistic combination of basic and translational research to further unravel the "disease-specific" contributory role of MIF, in order to seek and develop potent and selective drug-like MIF inhibitors as therapeutic agents. This symposium brings together pioneers in the field of MIF including, the discoverer of MIF (Prof. John David, MD). These pioneers will speak about their scientific quest towards increasing the fundamental understanding of MIF and controlling its biological activity in various pathologies.
(Courtesy of http://www.piramalhealthcare.com/nce)
Thu, Nov 01, 2012 - Fri, Nov 02, 2012
Piramal Research Center, Mumbai, India
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
